相关实验视频

Updated: Jul 8, 2025

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

肝炎C病毒NS5A的Ser235酸化是NS5A二分化和耐药性的必要条件

Wei-Ping Lee¹, Keng-Chang Tsai², Shi-Xian Liao³

¹Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.

|December 10, 2023

概括

肝炎C病毒 (HCV) 非结构蛋白5A (NS5A) 在Ser235的酸化是复制的关键. 赋予NS5A抑制剂耐药性的突变涉及改变的二分化,影响HCV治疗策略.

科学领域:

病毒学病毒学
分子生物学分子生物学
肝病学肝病学是一种肝病学.

背景情况:

肝炎C病毒 (HCV) 导致慢性肝病和癌症.
HCV NS5A蛋白对于病毒复制和组装至关重要.
NS5A抑制剂是组合治疗中重要的直接作用抗病毒药物 (DAA).

研究的目的:

阐明NS5A酸化和HCV中的二度化机制.
了解NS5A突变如何对NS5A抑制剂产生抗性.
研究Ser235酸化在NS5A功能和抑制剂耐药性中的作用.

主要方法:

局部导向的突变发生,以产生相仿NS5A替代物 (Ser-to-Asp).
使用细胞培养系统和HCV复制品对NS5A二分化进行分析.
在JFH1和突变菌株中评估NS5A抑制剂耐药性.

主要成果:

在Ser235中NS5A的相仿替代导致了抑制剂耐药的二分化.
酸化Ser235对于NS5A-WT二分化是必不可少的,但对于Y93H突变二分化却不是.
对于NS5A-WT二元化,HCV NS3-5A蛋白质是必需的,但对于NS5A-Y93H二元化,并非如此.

结论:

自发的NS5ASer235酸化和随后的二分化有助于对NS5A抑制剂的耐药性.
了解这些机制对于开发有效的HCV疗法至关重要.
向NS5A的酸化和二元化可以克服治疗耐药性.

关键词:

药物耐药性药物耐药性药物耐药性肝炎C病毒感染者在NS5A二元化过程中.在Ser235的酸化中.

更多相关视频

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

相关概念视频

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...